
May 2 at 11:30 am PDT | Mental Health in ESG: Increasing Employer Value and Impact

May 2 at 11:30 am PDT | Is Critical Infrastructure in Place to Respond to Another Pandemic?

May 2 at 10:00 am PDT | Cures on the Horizon

May 2 at 10:00 am PDT | Tipping Point for US Health-Care System Transformation

May 2 at 8:00 am PDT | Beyond the Pandemic: Health and Medicine in a Connected World

The Future of Work in the Life Sciences

An Update from MI Health—July 2024

FasterCures Quarterly Update—July 2024

Milken Institute Statement on Newly Released FDA Guidance on Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Trials

Comments on Collection of Race and Ethnicity Data in Clinical Trials and Clinical Studies for FDA-Regulated Medical Products, Federal Register Docket FDA-2016-D-3561
